Morningstar

Galderma Finance Chief to Step Down, Months After Joining Company

Provided by Dow Jones

By Joshua Kirby

Swiss skincare group Galderma said its chief financial officer has decided to leave the company after just months in the job.

Luigi La Corte, who joined Galderma in April and took on the role the following month, will continue as CFO over a transition period, with further details regarding his succession to be set out "in due course," the company said Monday. La Corte is leaving to pursue a "significant" new opportunity elsewhere, Galderma said.

The company, which makes Cetaphil and Alastin skincare products and is attempting to launch a rival treatment to AbbVie's Botox, meanwhile, said it wis as proposing two new board members. Rosalind Brewer and Petra Rumpf bring "extensive leadership and governance experience, alongside expertise spanning consumer-facing businesses, healthcare, medtech and life sciences," the company said.

Brewer is a former chief executive of drugstore chain Walgreens Boots Alliance, while Rumpf serves on the boards at Swiss firms Straumann Group and SHL Medical.

The proposed appointments demonstrate the company's commitment to strengthening the board with the capabilities to support its next phase of growth, Galderma said.

Write to Joshua Kirby at joshua.kirby@wsj.com; @joshualeokirby

(END) Dow Jones Newswires

November 02, 2026 12:42 ET (17:42 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

The articles, information, and content displayed on this webpage may include materials prepared and provided by third parties. Such third-party content is offered for informational purposes only and is not endorsed, reviewed, or verified by Morningstar.

Morningstar makes no representations or warranties regarding the accuracy, completeness, timeliness, or reliability of any third-party content displayed on this site. The views and opinions expressed in third-party content are those of the respective authors and do not necessarily reflect the views of Morningstar, its affiliates, or employees.

Morningstar is not responsible for any errors, omissions, or delays in this content, nor for any actions taken in reliance thereon. Users are advised to exercise their own judgment and seek independent financial advice before making any decisions based on such content. The third-party providers of this content are not affiliated with Morningstar, and their inclusion on this site does not imply any form of partnership, agency, or endorsement.

Popular

4 Growth Stocks to Buy While They’re Still Undervalued

Plus, the outlook for the AI trade after last week’s selloff.
David Sekera, CFA and Sarah Hansen

3 of the Best Core Stocks to Own

These core stocks with wide economic moats are good long-term investments if you can buy them at a discount.
Susan Dziubinski

Retirees: 5 Reasons to Consider Index Funds and ETFs

Low fees are just the start. These funds can also make it easier to draw cash for living expenses and manage your portfolio.
Christine Benz

3 Great New ETFs From 2026

These ETFs stand out from the rest.
Brendan McCann, CFA

This Newly Undervalued Stock Has Plenty of Growth Ahead

After the recent selloff, this 4-star stock looks more attractive as demand grows for the materials used to make advanced chips.
Seth Goldstein, CFA

Sponsor Center

Site Index
United States Flag United States

© Copyright 2026 Morningstar, Inc. All rights reserved. Dow Jones Industrial Average, S&P 500, Nasdaq, and Morningstar Index (Market Barometer) quotes are real-time.